|
ASSAY and Drug Development Technologies
Recombinant Baculoviruses Used to Study Estrogen Receptor Function in Human Osteosarcoma Cells
To cite this article:
William C. Clay, J. Patrick Condreay, Linda B. Moore, Susan L. Weaver, Michael A. Watson, Thomas A. Kost, Jennifer J. Lorenz.
ASSAY and Drug Development Technologies.
December 2003,
1(6): 801-810.
doi:10.1089/154065803772613435.
William C. Clay Department of Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research, Research Triangle Park, NC J. Patrick Condreay Department of Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research, Research Triangle Park, NC Linda B. Moore Department of Systems Research and Protein Biochemistry, GlaxoSmithKline Discovery Research, Research Triangle Park, NC Susan L. Weaver Department of Systems Research and Protein Biochemistry, GlaxoSmithKline Discovery Research, Research Triangle Park, NC Michael A. Watson Department of High Throughput Biology and Protein Biochemistry, GlaxoSmithKline Discovery Research, Research Triangle Park, NC Thomas A. Kost Department of Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research, Research Triangle Park, NC Jennifer J. Lorenz Department of Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research, Research Triangle Park, NC We report that modified baculoviruses, termed BacMam viruses, can efficiently deliver multiple genes into mammalian cells to generate a heterologous transcription factor/reporter gene system. Using human estrogen receptor (ER) as a model nuclear receptor, we demonstrate how this approach can be successfully applied to assay development in Saos-2 human osteosarcoma cells. BacMam viruses containing full-length cDNAs were constructed for both human ER subtypes, ERα and ERβ, and a third BacMam virus containing an ER-responsive reporter gene cassette. Using these viruses, we found that BacMam-ER expression/reporter constructs could be used to profile the effects of the agonist 17β-estradiol and the partial agonist raloxifene in human Saos-2 cells. A comparison of assay data obtained with the BacMam-based system with that using standard DNA transfections demonstrates that the two systems are functionally equivalent, giving comparable EC50 and IC50 values for estrogen and estrogen plus raloxifene treatments, respectively. Our results indicate that BacMam-mediated gene transfer offers a novel and efficient method for delivery of nuclear receptors and associated genes for mammalian cell-based assay development.  This paper was cited by:Identification of regions of the P2X
7
receptor that contribute to human and rat species differences in antagonist effects A D Michel, W C Clay, S W Ng, S Roman, K Thompson, J P Condreay, M Hall, J Holbrook, D Livermore, S Senger British Journal of Pharmacology. Dec 2008, Vol. 155, No. 5: 738-751 CrossRef Cloning and pharmacological characterization of the guinea pig P2X
7
receptor orthologue E Fonfria, W C Clay, D S Levy, J A Goodwin, S Roman, G D Smith, J P Condreay, A D Michel British Journal of Pharmacology. Mar 2008, Vol. 153, No. 3: 544-556 CrossRef BacMam technology and its application to drug discovery Robert S Ames, Thomas A Kost, J Patrick Condreay Expert Opinion on Drug Discovery. Jan 2008, Vol. 2, No. 12: 1669-1681 CrossRef Direct labelling of the human P2X
7
receptor and identification of positive and negative cooperativity of binding A D Michel, L J Chambers, W C Clay, J P Condreay, D S Walter, I P Chessell British Journal of Pharmacology. Jun 2007, Vol. 151, No. 1: 84-95 CrossRef Baculovirus as versatile vectors for protein expression in insect and mammalian cells Thomas A Kost, J Patrick Condreay, Donald L Jarvis Nature Biotechnology. Jun 2005, Vol. 23, No. 5: 567-575 CrossRef Baculovirus as a highly efficient expression vector in insect and mammalian cells Yu-chen HU Acta Pharmacologica Sinica. May 2005, Vol. 26, No. 4: 405-416 CrossRef
|
|